Turning Point Therapeutics (TPTX) Announces 2021 Milestone Targets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Turning Point Therapeutics Announces 2021 Milestone Targets
January 11, 2021 7:40 AM ESTPresent Updated Data from TRIDENT-1 Study in TKI-Naive Patients with ROS1-Positive Non-Small Cell Lung Cancer Jan. 31 at World Conference on Lung CancerProvide TRIDENT-1 Study Timeline in First Quarter Provide Clinical Data Interim Updates from Multiple Studies, including Phase 1/2 TRIDENT-1, Phase 1 SHIELD-1 and Phase 1 Study of TPX-0046Submit Fourth Drug Candidate IND in First QuarterInitiate Combination Studies for Repotrectinib and TPX-0022Outline Precision Therapy Research Vision in Second HalfCompany also Updates Cash, Cash... More
